శోధన
తెలుగు లిపి
  • English
  • 正體中文
  • 简体中文
  • Deutsch
  • Español
  • Français
  • Magyar
  • 日本語
  • 한국어
  • Монгол хэл
  • Âu Lạc
  • български
  • Bahasa Melayu
  • فارسی
  • Português
  • Română
  • Bahasa Indonesia
  • ไทย
  • العربية
  • Čeština
  • ਪੰਜਾਬੀ
  • Русский
  • తెలుగు లిపి
  • हिन्दी
  • Polski
  • Italiano
  • Wikang Tagalog
  • Українська Мова
  • ఇతరులు
  • English
  • 正體中文
  • 简体中文
  • Deutsch
  • Español
  • Français
  • Magyar
  • 日本語
  • 한국어
  • Монгол хэл
  • Âu Lạc
  • български
  • Bahasa Melayu
  • فارسی
  • Português
  • Română
  • Bahasa Indonesia
  • ไทย
  • العربية
  • Čeština
  • ਪੰਜਾਬੀ
  • Русский
  • తెలుగు లిపి
  • हिन्दी
  • Polski
  • Italiano
  • Wikang Tagalog
  • Українська Мова
  • ఇతరులు
శీర్షిక
ట్రాన్స్క్రిప్ట్
తదుపరి
 

ప్రొఫెసర్ యాకోవ్ నహ్మియాస్: బయో ఇంజనీరింగ్ మెరుగైన ప్రపంచం కోసం

వివరాలు
డౌన్లోడ్ Docx
ఇంకా చదవండి
February 2014 saw Dr. Nahmias win a Rappaport Prize for Excellence in Biomedical Research. Collaborating with investigators at Massachusetts General Hospital in the US, he identified a grapefruit molecule called naringenin that can block virus replications. Later that year, he became an associate professor at his university and took charge of the MicroLiver Technologies Laboratory, studying liver development, regeneration, and metabolism.

By early 2017, Professor Nahmias had pieced together various aspects of his academic work and was ready to focus on his first entrepreneurial goal. He founded Tissue Dynamics Ltd., a biotechnology company that develops and provides advanced toxicology screening services for the pharmaceutical and cosmetic industries. Professor Nahmias and his company produced a model of the human kidney. But they also embedded electro-optical microsensors into the tissues for constant monitoring throughout experiments. In this way, they knew in real time how a drug was working and when it was not.

Under the guidance of Professor Nahmias, Tissue Dynamics is leading the way to a future where human-on-a-chip technology accelerates the pace and reduces the cost of developing new drugs while keeping our furry friends out of the laboratory.

He founded Future Meat Technologies in April 2018 and once again assumed the responsibilities of a chief scientific officer. Upon completion, the company began producing 500 kilograms of cultured meat daily. As it turned out, the genetic complexity of Future Meat’s product gave it the texture, authentic smell, and flavor that the public wanted.

By November 2021, the company’s founder and chief scientific officer had also become its president. The following year, he changed the firm’s name to Believer Meats and decided to open a commercial-scale production center in North Carolina, USA. Construction began in December 2022 on an 18,000-square-meter facility that will cultivate beef, pork, lamb and chicken meat without killing any animal-people.
మరిన్ని చూడండి
తాజా వీడియోలు
2024-11-05
10 అభిప్రాయాలు
2024-11-05
10 అభిప్రాయాలు
2024-11-04
2935 అభిప్రాయాలు
2024-11-04
973 అభిప్రాయాలు
షేర్
భాగస్వామ్యం చేయండి
పొందుపరిచిన
దీని వద్ద ప్రారంభించు
డౌన్లోడ్
మొబైల్
మొబైల్
ఐఫోన్
ఆండ్రోయిడ్
మొబైల్ బ్రౌజర్లో చూడండి
GO
GO
Prompt
OK
అప్ప్
QR కోడ్ను స్కాన్ చేయండి లేదా డౌన్లోడ్ చేయడానికి సరైన ఫోన్ సిస్టమ్ను ఎంచుకోండి
ఐఫోన్
ఆండ్రోయిడ్